Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $765.45 billion, total revenue of $166.25 billion and a weighted average PE ratio of 51.46.
Market Cap
765.45B
Revenue
166.25B
Profits
14.87B
PE Ratio
51.46
Profit Margin
8.95%
Dividend Yield
0.19%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 217.43B | -0.24% | 1,317,550 | 43.74B |
| 2 | DHR | Danaher Corporation | 156.25B | - | 4,551,728 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.09B | -1.65% | 468,313 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 41.62B | -0.05% | 1,301,662 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 37.57B | -1.32% | 1,426,026 | 15.90B |
| 6 | MTD | Mettler-Toledo International Inc. | 28.66B | -0.64% | 139,225 | 3.94B |
| 7 | NTRA | Natera, Inc. | 28.19B | 1.80% | 1,288,835 | 2.12B |
| 8 | WAT | Waters Corporation | 22.59B | 0.03% | 630,598 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 22.13B | -0.37% | 1,154,712 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.80B | -0.34% | 923,780 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 18.44B | 0.62% | 1,063,152 | 4.29B |
| 12 | MEDP | Medpace Holdings, Inc. | 16.62B | -0.16% | 184,321 | 2.36B |
| 13 | EXAS | Exact Sciences Corporation | 12.70B | -1.06% | 1,734,820 | 3.08B |
| 14 | ICLR | ICON Public Limited Company | 12.38B | -0.71% | 562,711 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 11.89B | 0.25% | 1,732,281 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 10.51B | -0.72% | 924,296 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.61B | -0.74% | 1,278,735 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 8.26B | -0.83% | 1,894,487 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.80B | 2.31% | 1,002,569 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.44B | -2.31% | 2,912,694 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.02B | 0.50% | 129,570 | 209.03M |
| 22 | WGS | GeneDx Holdings Corp. | 3.70B | -1.76% | 513,609 | 402.19M |
| 23 | VCYT | Veracyte, Inc. | 3.11B | -1.30% | 1,020,719 | 495.14M |
| 24 | GRAL | GRAIL, Inc. | 3.10B | -4.29% | 1,165,828 | 141.83M |
| 25 | TWST | Twist Bioscience Corporation | 1.62B | -10.13% | 5,759,020 | 376.57M |
| 26 | NEOG | Neogen Corporation | 1.39B | 0.31% | 2,011,359 | 886.89M |
| 27 | NEO | NeoGenomics, Inc. | 1.34B | 3.30% | 2,152,567 | 709.16M |
| 28 | OPK | OPKO Health, Inc. | 982.66M | - | 2,637,449 | 642.07M |
| 29 | CSTL | Castle Biosciences, Inc. | 976.36M | -2.02% | 477,431 | 343.53M |
| 30 | FLGT | Fulgent Genetics, Inc. | 899.55M | -1.66% | 440,003 | 315.55M |
| 31 | CDNA | CareDx, Inc | 819.58M | 0.41% | 845,523 | 358.00M |
| 32 | PSNL | Personalis, Inc. | 666.92M | -1.32% | 1,125,859 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 625.46M | 5.75% | 1,136,272 | 825.30M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 212.12M | -5.73% | 209,370 | 4.40M |
| 35 | XGN | Exagen Inc. | 204.19M | -3.64% | 368,410 | 63.60M |
| 36 | MDXH | MDxHealth SA | 180.17M | -7.56% | 754,616 | 103.07M |
| 37 | PRE | Prenetics Global Limited | 165.07M | -9.43% | 132,922 | 77.08M |
| 38 | BNR | Burning Rock Biotech Limited | 126.40M | 3.71% | 76,294 | 74.86M |
| 39 | FONR | FONAR Corporation | 92.62M | - | 42,714 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 63.65M | 1.27% | 81,025 | 80.17M |
| 41 | NOTV | Inotiv, Inc. | 35.39M | -1.90% | 332,484 | 505.30M |
| 42 | PRPO | Precipio, Inc. | 31.31M | -0.97% | 17,442 | 21.24M |
| 43 | BNBX | Applied DNA Sciences, Inc. | 12.41M | -8.36% | 55,421 | 3.74M |
| 44 | PRPH | ProPhase Labs, Inc. | 11.63M | 11.11% | 1,539,065 | 5.59M |
| 45 | CHEK | Check-Cap Ltd. | 11.56M | 16.86% | 210,546 | - |
| 46 | ADVB | Advanced Biomed Inc. | 9.45M | -2.57% | 238,216 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 8.26M | -2.13% | 128,837 | 7.68M |
| 48 | MYNZ | Mainz Biomed N.V. | 7.74M | -2.05% | 964,474 | 659.94K |
| 49 | NDRA | ENDRA Life Sciences Inc. | 5.04M | 1.98% | 25,623 | - |
| 50 | XWEL | XWELL, Inc. | 4.78M | 0.12% | 1,340,644 | 30.60M |
| 51 | ISPC | iSpecimen Inc. | 3.48M | 1.26% | 88,564 | 5.91M |